Evidence map›Paper›PMID 20807497›Full record

ArticleAnalytical biochemistry2011

A magnetic bead-based protein kinase assay with dual detection techniques.

Guangchang Zhou, Juliesta E Sylvester, Ding Wu, Darren R Veach, Stephen J Kron

Abstract read
In one paragraph

Article in Analytical biochemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Guangchang ZhouLudwig Center for Metastasis Research, The University of Chicago, IL 60637, USA.
Juliesta E Sylvester
Ding Wu
Darren R Veach
Stephen J Kron
University of Chicago · USMemorial Sloan Kettering Cancer Center · US

Funding

Molecular screening: MALDI-TOF scanning of peptides(RMI)R01HG003864 · NHGRI · UNIVERSITY OF CHICAGO · PI KRON, STEPHEN J. · 2005 to 2008
$2.3M
Solid-state analysis of kinase activity in cell extractsR01GM074691 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI PALECEK, SEAN P · 2006 to 2010
$1.3M
MALDI Imaging of Cancer Signaling SignaturesR21CA126764 · NCI · UNIVERSITY OF CHICAGO · PI KRON, STEPHEN J. · 2008 to 2009
$381k
NCI NIH HHS CA126764NCI NIH HHS R21 CA126764NHGRI NIH HHS HG003864NHGRI NIH HHS R01 HG003864NIGMS NIH HHS GM074691NIGMS NIH HHS R01 GM074691
6 · The paper itself

Abstract

A novel magnetic bead-based protein kinase assay was developed using MALDI-TOF mass spectrometry (MALDI-TOF MS) and immunochemifluorescence as two independent detection techniques. Abltide substrate was immobilized onto magnetic beads via noncovalent biotin-streptavidin interactions. This noncovalent immobilization strategy facilitated peptide release and allowed MALDI-TOF MS analysis of substrate phosphorylation. The use of magnetic beads provided rapid sample handling and allowed secondary analysis by immunochemifluorescence to determine the degree of substrate phosphorylation. This dual detection technique was used to evaluate the inhibition of c-Abl kinase by imatinib and dasatinib. For each inhibitor, IC₅₀ (half-maximal inhibitory concentration) values determined by these two different detection methods were consistent and close to values reported in the literature. The high-throughput potential of this new approach to kinase assays was preliminarily demonstrated by screening a chemical library consisting of 31 compounds against c-Abl kinase using a 96-well plate. In this proof-of-principle experiment, both MALDI-TOF MS and immunochemifluorescence were able to compare inhibitor potencies with consistent values. Dual detection may significantly enhance the reliability of chemical library screening and identify false positives and negatives. Formatted for 96-well plates and with high-throughput potential, this dual detection kinase assay may provide a rapid, reliable, and inexpensive route to the discovery of small-molecule drug leads.

Indexed as

MagneticsAntibodiesBenzamidesDasatinibImatinib MesylateImmunoassayLuminescent MeasurementsPeptidesPhosphorylationPiperazinesProtein Kinase InhibitorsProto-Oncogene Proteins c-ablPyrimidinesSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationThiazolesAntibodiesBenzamidesDasatinibImatinib MesylatePeptidesPiperazinesProtein Kinase InhibitorsProto-Oncogene Proteins c-ablPyrimidinesThiazoles

Identifiers

PMID20807497
PMCPMC3034244
OpenAlexW2062839995

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.